The impact of familial Mediterranean fever on reproductive system
Muyesser Nergiz Yanmaz1, Ayşet Jane Özcan, Kadir Savan
1Istanbul Kemerburgaz University School of Medicine, Internal Medicine and Rheumatology, Medicalpark Hospital, Kültür sok No. 1, 34160, Istanbul, Turkey, muyessera@hotmail.com.
Abstract:
Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent attacks of fever, peritonitis, pleuritis, arthritis, or erysipelas-like skin lesion. FMF is the most common periodic febrile syndrome affecting more than 150,000 people worldwide. The majority of patients develop FMF before the age of 20. FMF may cause amyloidosis, which mainly affects the kidneys but may also be accumulated in other organs such as the heart, gastrointestinal tract, and reproductive organs. FMF being a systemic disorder with a risk for amyloidosis, affecting patients in their childbearing years, and with its lifelong colchicine therapy raises concern about its effect on the reproductive system. In this article, we review the impact of FMF and its treatment to the reproductive system of male and female patients, pregnancy, and lactation.
Insights
Familial Mediterranean fever (FMF) is a genetic disorder impacting fertility. This review examines FMF and colchicine treatment effects on male and female reproductive health, pregnancy, and lactation.
Area of Science:
- Genetics and Immunology
- Reproductive Medicine
Background:
- Familial Mediterranean fever (FMF) is a prevalent autosomal recessive autoinflammatory disorder.
- Characterized by recurrent febrile episodes and potential systemic complications like amyloidosis.
- FMF affects numerous individuals, often diagnosed before age 20, posing reproductive health concerns due to lifelong treatment.
Purpose of the Study:
- To comprehensively review the impact of FMF and its standard treatment, colchicine, on the reproductive systems of both males and females.
- To assess the implications for pregnancy and lactation in patients with FMF.
Main Methods:
- Literature review of studies on FMF, colchicine therapy, and reproductive outcomes.
- Analysis of data concerning fertility, pregnancy complications, and lactation in FMF patients.
Main Results:
- FMF and its treatment can affect male and female reproductive health.
- Potential impacts include fertility issues and considerations during pregnancy and lactation.
Conclusions:
- Understanding the reproductive implications of FMF and its management is crucial for patient care.
- Further research may be needed to optimize reproductive outcomes for FMF patients.
More Related Videos
Related Concept Videos
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Spermatogenesis
Infertility in Males
Disorders of the Female Reproductive System
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....


